Natural course of HCV infection in childhood cancer survivors

Supportive Care in Cancer

Volumn 18, Issue 11, 2010, Pages 1413-1420

  Fioredda, Francesca ^a   Moser, Andrea ^b   Bertoluzzo, Luisella ^a   Lackner, Herwig ^b   Giacchino, Raffaella ^a   LaSpina, Milena ^c   Lazier, Luisella ^d   Riva, Caterina ^d   Giacchino, Mareva ^d   Fraschini, Donatella ^e   Frey, Eva ^f   Sementa, Angela ^a   Pistorio, Angela ^a   Haupt, Riccardo ^a  

^a G GASLINI INSTITUTE   (Italy)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF CATANIA   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e SAN GERARDO HOSPITAL   (Italy)

^f ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Chronic hepatitis C; HCVafter cancer; Long term survivors

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKYLATING AGENT; ANTIMETABOLITE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; AGE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER SURVIVOR; CHEMORADIOTHERAPY; CHILD; CHILDHOOD CANCER; COHORT ANALYSIS; CYTOLYSIS; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FIBROSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PATHOLOGIST; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ADULT; BIOPSY; EUROPE; LIVER FUNCTION TEST; NEOPLASM; ONSET AGE; PATHOLOGY; RISK FACTOR; SURVIVOR; TIME;

ADULT; AGE OF ONSET; BIOPSY; CHILD; DISEASE PROGRESSION; EUROPE; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; LIVER FUNCTION TESTS; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVORS; TIME FACTORS; YOUNG ADULT;

EID: 79952115198     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-009-0763-7     Document Type: Article

References (35)

1. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease (1998) MMWR 16:1-39
2. Seeff LB, Hoofnagle JH (2003) Appendix: The national institutes of health consensus development conference management of hepatitis C. Clin Liver Dis 7:261-287
3. Chen SL, Morgan TR (2006) The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 3:47-52
4. Choo Q, Kuo G, Weiner A, Overby L, Bradley D, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244(4902):359-362
5. Kuo G, Choo Q, Alter H, Gitnick G, Redeker A, Purcell R, Miyamura T, Dienstag J, Alter M, Stevens C (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244(4902):362-364
6. Lauer GM, Bruce D, Bruce DW (2001) Hepatitis C infection. New Engl J Med 5:41-52
7. Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, Hürter D, Nawrocki M, Kruska L, Hensel F, Petry W, Häussinger D (1998) Prognosis of chronic hepatitis C: Results of a large, prospective cohort study. Hepatology 28:1687-1695
8. Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, Hashimoto E, Lefkowitch JH, Ludwig J, Okuda K (1996) The long-term pathological evolution of chronic hepatitis C. Hepatology 23:1334-1340
9. Badizadegan K, Jonas MM, Ott MJ, Nelson SP, Perez-Atayde AR (1998) Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 28:1416-1423
10. Bortolotti F, Jara P, Diaz C, Vajro P, Hierro L, Giacchino R, de la Vega A, Crivellaro C, Camarena C, Barbera C et al (1994) Posttransfusion and community-acquired hepatitis C in childhood. J Pediatr Gastroenterol Nutr 18(3):279-283
11. Casiraghi MA, De Paschale M, Romanò L, Biffi R, Assi A, Binelli G, Zanetti AR (2004) Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology 39:90-96
12. Goodman ZD, Makhlouf HR, Liu L, Balistreri W, Gonzalez-Peralta RP, Haber B, Jonas MM, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, Smith LJ, Robuck PR, Scharz KB (2008) Pathology of chronic hepatitis C in children: Liver biopsy findings in the Peds-C Trial. Hepatology 47:836-843
13. Guido M, Rugge M, Jara P, Hierro L, Giacchino R, Larrauri J, Zancan L, Leandro G, Marino CE, Balli F, Bagni A, Timitilli A, Bortolotti F (1998) Chronic hepatitis C in children: The pathological and clinical spectrum. Gastroenterology 115:1525-1529
14. Iorio R, Giannattasio A, Sepe A, Terracciano LM, Vecchione R, Vegnente A (2005) Chronic hepatitis C in childhood: An 18-year experience. Clin Infect Dis 41:1431-1437
15. Jara P, Resti M, Hierro L, Giacchino R, Barbera C, Zancan L, Crivellaro C, Sokal E, Azzari C, Guido M, Bortolotti F (2003) Chronic hepatitis C virus infection in childhood: Clinical patterns and evolution in 224 white children. Clin Infect Dis 36:275-280
16. Mohan P, Colvin C, Glymph C, Chandra RR, Kleiner DE, Patel KM, Luban NL, Alter HJ (2007) Clinical spectrum and histopathologic features of chronic hepatitis C infection in children. J Pediatr 150:168-74
17. Vogt M, Lang T, Frösner G, Klingler C, Sendl AF, Zeller A, Wiebecke B, Langer B, Meisner H, Hess J (1999) Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blooddonor screening. N Engl J Med 341:866-870
18. Zein NN (2007) Hepatitis C in children: Recent advances. Curr Opin Pediatr 19:570-574
19. Peffault de Latour R, Lévy V, Asselah T, Marcellin P, Scieux C, Adès L, Traineau R, Devergie A, Ribaud P, Espérou H, Gluckman E, Valla D, Socié G (2004) Long-term outcome of hepatitis C infection after bone marrow transplantation. Blood 103:1618-1624
20. Strasser SI, Sullivan KM, Myerson D, Spurgeon CL, Storer B, Schoch HG, Murakami CS, McDonald GB (1999) Cirrhosis of the liver in long-term marrow transplant survivors. Blood 93:3259-3266
21. Castellino S, Lensing S, Riely C, Rai SN, Davila R, Hayden RT, Fleckenstein J, Levstik M, Taylor S, Dean PJ, Kippenbrock S, Pope J, Carr J, Strickland DK, Hudson MM (2004) The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: An update of the St Jude Children's Research Hospital hepatitis C seropositive cohort. Blood 103: 2460-2466
22. Cesaro S, Bortolotti F, Petris MG, Brugiolo A, Cusinato R, Guido M, Rossetti F, Masiero L, Zanesco L (1997) Chronic hepatitis C virus infection after treatment for pediatric malignancy. Blood 90:1315-1320
23. Locasciulli A, Testa M, Pontisso P, Benvegnù L, Fraschini D, Corbetta A, Noventa F, Masera G, Alberti A (1997) Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood 90:4628-4633
24. Paul IM, Sanders J, Ruggiero F, Andrews T, Ungar D, Eyster ME (1999) Chronic hepatitis C virus infections in leukemia survivors: Prevalence, viral load, and severity of liver disease. Blood 93:3672-3677
25. Scheuer PJ, Standish RA, Dhillon AP (2002) Scoring of chronic hepatitis. Clin Liver Dis 6:335-347
26. Fioredda F, Gigliotti AR, Haupt R, Calevo MG, Giudice CL, Bocciardo L, Giacchino R (2005) HCV infection in very-longterm survivors after cancer chemotherapy and bone marrow transplantation: A single-center experience. J Pediatr Hematol Oncol 27:481-485
27. Einav S, Koziel MJ (2002) Immunopathogenesis of hepatitis C virus in the immunosuppressed host. Transpl Infect Dis 4:85-92
28. Bortolotti F, Muratori L, Jara P, Hierro L, Verrucchi G, Giacchino R (2003) Hepatitis C virus infection associated with liver-kidney microsomal antibody type I(LKM) autoantibodies in children. J Pediatr 142:185-190
29. Zhao J, Kim KD, Yang X, Auh S, Fu YX, Tang H (2008) Hyper innate responses in neonates lead to increased morbidity and mortality after infection. Proc Natl Acad Sci U S A 10:7528-7533
30. Hoshiyama A, Kimura A, Fujisawa T, Kage M, Kato (2000) Clinical and histologic features of chronic hepatitis C virus infection after blood transfusion in Japanese children. Pediatrics 105:62-65
31. Li Y, Chang M, Abar O, Garcia V, Rowland C, Catanese J, Ross D, Broder S, Shiffman M, Cheung R, Wright T, Friedman SL, Sninsky J (2009) Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection. J Hepatol 51:750-757
32. Pradat P, Alberti A, Poynard T, Esteban JI, Weiland O, Marcellin P, Badalamenti S, Trepo C (2003) Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative study. Hepatology 37:950-951
33. Toniutto P, Fabris C, Bitetto D, Faleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M (2007) Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation. J Gastroenterol Hepatol 22:194-198
34. Liu CH, Lin JW, Tsai FC, Yang PM, Lai MY, Chen JH, Kao JH, Chen DS (2006) Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases. Liver Int 26:1087-1094
35. Persico M, Perrotta S, Persico E, Terracciano L, Folgori A, Ruggeri L, Nicosia A, Vecchione R, Mura VL, Masarone M, Torella R (2006) Hepatitis C virus carriers with persistently normal ALT levels: Biological peculiarities and update of the natural history of liver disease at 10 years. J Viral Hepat 13: 290-296